MicuRx Pharmaceuticals, Inc., a privately-held bio-pharmaceutical company developing next-generation antibiotics, says it has raised $25 million in series B financing. The round is led by BVCF, a private equity and growth fund specializing in the life sciences industry, the round also includes existing investors Morningside Group and Devon Park Bioventures. MicuRx Pharmaceuticals says it will […]

Visit ChinaMoneyNetwork.com for more great China Money Podcast audio and video Internet episodes covering important investment news and financial events in China, as well as daily news updates on important China business news happenings. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.